ADAM17 and metastatic malignant neoplasm in the lymph nodes: Li et al. obtained similar results: ADAM17 expression was associated with poor OS (HR = 2.239, 95% CI = 1.516–3.305, p < 0.001) and lymph node metastasis (OR = 2.161, 95% CI = 1.115–4.190, p = 0.022) [173].